Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.

France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.

Research from Stada shows that while a quarter of European consumers increased their dietary supplement intake compared to last year, one in five have cut back spending on such products. These are among the findings of the Stada Health Report 2023 which asked 32,000 people more than 30 questions covering topics such as health prevention and satisfaction with national healthcare systems.

A round-up of the latest appointments in Europe's health and wellness markets: Norgine names former L'Oreal exec as COO; Lonza appoints chairman to interim-CEO role; and Sabinsa hires head for new French office.

Popular OTC sore throat treatment flurbiprofen can possibly mask the symptoms of infection and lead to treatment delays, according to EU medicines regulators. Products sold in the EU containing flurbiprofen will soon be required to carry information warning patients and healthcare professionals about this risk. 

New Zealand will likely be the next country to ban sales of popular OTC dry cough treatment pholcodine following a safety alert issued by the World Health Organization.